| Date of birth | 1949 |
| Nationality | Swiss and American |
Professional Development
| 2009 - today | Director, Pre-clinical Development, Alfama, MA, USA |
| 2007 - 2009 | Consultant to HealthCare Ventures (HCV) and Edmond de Rothschild Investment Partners (EdRIP) |
| 1996 - 2007 | Executive VP, Science and Technology, ImmunoGen, Inc. Cambridge, MA, USA |
| 1994 - 1996 | Senior VP, Research and Development, ImmunoGen, Inc. Cambridge, MA, USA |
| 1995 - 2006 | Member of the Supervisory Board of ImmunoGen, Inc. Cambridge, MA, USA |
| 1987 - 1994 | VP Research, ImmunoGen, Inc. Cambridge, MA, USA |
| 1987 - 1996 | Lecturer in Pathology, Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, USA |
| 1986 - 1987 | Assistant Professor in Pathology, Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, USA |
| 1981 - 1986 | Assistant Professor in Pathology, Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, USA |
Education
| 1978 - 1981 | Postdoctoral Fellow, Chemistry Department, Harvard University, Cambridge, MA, USA |
| 1978 | Dr.sc.nat. (Chemistry) Swiss Federal Institute of Technology, Zurich (ETH Zürich); Awarded the ETH Zürich Silver Medal for outstanding thesis |
| 1973 | M.S. (Chemistry) Swiss Federal Institute of Technology, Zurich (ETH Zürich) |
Membership in other Supervisory Boards and other current mandates
Currently no other mandates.
Dr. Blättler is a member of MorphoSys AG's Supervisory Board since 2007.
